What is it about?
Mutations in the phosphodiesterase 4D, that regulates availability of the secondary messenger cyclic adenosine monophosphate (cAMP), cause a rare disease presenting skeletal defects as well as intellectual disability in most cases. The net effect of the mutations is reduced cAMP signalling, but the molecular mechanisms leading to this are poorly understood. It has been suggested that mutated PDE4D has increased activity leading to reduced signalling. Here we propose novel mechanisms including: • Mutated PDE4D altered localisation affects strict coordination of its activity reducing signalling. • Reduced dimerization of mutated PDE4D increases the proportion of the monomeric form leading to reduced signalling.
Featured Image
Why is it important?
Better understanding the disease mechanisms is crucial to developing properly targeted effective therapeutic approaches.
Read the Original
This page is a summary of: Phosphodiesterase 4D activity in acrodysostosis-associated neural pathology: too much or too little?, Brain Communications, January 2024, Oxford University Press (OUP),
DOI: 10.1093/braincomms/fcae225.
You can read the full text:
Contributors
The following have contributed to this page







